Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: the Women's Angiographic Vitamin & Estrogen Trial.
暂无分享,去创建一个
J. Hsia | V. Bittner | M. Steffes | H. Gupta | M. Tripputi
[1] T. Rabelink,et al. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial , 2003, European journal of clinical investigation.
[2] J. Hsia,et al. Women's angiographic vitamin and estrogen trial: design and methods. , 2002, Controlled clinical trials.
[3] J. Hsia,et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.
[4] Y. Sakai,et al. Possible Relationship between Insulin Resistance and Remnant‐Like Lipoprotein Particles in Coronary Endothelial Dysfunction , 2002, Clinical cardiology.
[5] C. Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[6] Deborah Grady,et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.
[7] R. Krauss,et al. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. , 2002, Journal of lipid research.
[8] K. Kugiyama,et al. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. , 2001, The American journal of cardiology.
[9] A. Yonemura,et al. Remnant-like particles cholesterol is higher in diabetic patients with coronary artery disease. , 2001, Metabolism: clinical and experimental.
[10] E. Schaefer,et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. , 2001, The American journal of cardiology.
[11] M. Nieminen,et al. Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. , 2001, Atherosclerosis.
[12] A. Wakatsuki,et al. Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women. , 2001, Journal of the American College of Cardiology.
[13] D. Reboussin,et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000, The New England journal of medicine.
[14] K. Nakajima,et al. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[15] H. Masuoka,et al. Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels. , 2000, American heart journal.
[16] M. Sanada,et al. The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women. , 2000, Maturitas.
[17] J. Davignon,et al. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[18] H Yasue,et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. , 1999, Circulation.
[19] K. Nakajima,et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. , 1999, Atherosclerosis.
[20] T. Inoue,et al. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. , 1998, Atherosclerosis.
[21] H. Masuoka,et al. Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease. , 1998, American heart journal.
[22] P. Wilson,et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. , 1998, Clinical chemistry.
[23] M. Nieminen,et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. , 1997, Circulation.
[24] S. Azen,et al. Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin , 1994, Circulation.
[25] D H Blankenhorn,et al. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. , 1990, Circulation.
[26] E. Barrett-Connor,et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.
[27] R. Blumenthal,et al. Heart and estrogen/progestin replacement study follow-up (HERS-II) 1. Cardiovascular outcomes during 6.8 years of hormone therapy , 2002 .
[28] P. Wilson,et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. , 2001, Atherosclerosis.
[29] A. Hamsten,et al. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. , 2001, Journal of lipid research.